Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction.
Saved in:
| Title: | Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction. |
|---|---|
| Authors: | Lewis GA; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, England.; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England., Rosala-Hallas A; Liverpool Clinical Trials Centre, Clinical Directorate, Faculty of Health and Life Sciences, University of Liverpool (a member of Liverpool Health Partners), Alder Hey Children's NHS Foundation Trust, Liverpool, L12 2AP, England., Dodd S; Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool (a member of Liverpool Health Partners), Block F, Waterhouse Bld, 1-5 Brownlow Street, Liverpool, L69 3GL, England., Schelbert EB; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Cardiovascular Magnetic Resonance Center, Heart and Vascular Institute, Pittsburgh, PA, USA.; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA., Williams SG; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England., Cunnington C; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England., McDonagh T; King's College Hospital, Denmark Hill, London, SE5 9RS, UK., Miller CA; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, England. Christopher.Miller@manchester.ac.uk.; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England. Christopher.Miller@manchester.ac.uk.; Division of Cell-Matrix Biology & Regenerative Medicine, School of Biology, Faculty of Biology, Medicine & Health, Manchester Academic Health Science Centre, Wellcome Centre for Cell-Matrix Research, University of Manchester, Oxford Road, Manchester, M13 9PT, England. Christopher.Miller@manchester.ac.uk. |
| Source: | The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2022 Jul; Vol. 38 (7), pp. 1569-1578. Date of Electronic Publication: 2022 Feb 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 100969716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8312 (Electronic) Linking ISSN: 15695794 NLM ISO Abbreviation: Int J Cardiovasc Imaging Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35138474 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lewis+GA%22">Lewis GA</searchLink>; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, England.; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England.<br /><searchLink fieldCode="AU" term="%22Rosala-Hallas+A%22">Rosala-Hallas A</searchLink>; Liverpool Clinical Trials Centre, Clinical Directorate, Faculty of Health and Life Sciences, University of Liverpool (a member of Liverpool Health Partners), Alder Hey Children's NHS Foundation Trust, Liverpool, L12 2AP, England.<br /><searchLink fieldCode="AU" term="%22Dodd+S%22">Dodd S</searchLink>; Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool (a member of Liverpool Health Partners), Block F, Waterhouse Bld, 1-5 Brownlow Street, Liverpool, L69 3GL, England.<br /><searchLink fieldCode="AU" term="%22Schelbert+EB%22">Schelbert EB</searchLink>; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Cardiovascular Magnetic Resonance Center, Heart and Vascular Institute, Pittsburgh, PA, USA.; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Williams+SG%22">Williams SG</searchLink>; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England.<br /><searchLink fieldCode="AU" term="%22Cunnington+C%22">Cunnington C</searchLink>; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England.<br /><searchLink fieldCode="AU" term="%22McDonagh+T%22">McDonagh T</searchLink>; King's College Hospital, Denmark Hill, London, SE5 9RS, UK.<br /><searchLink fieldCode="AU" term="%22Miller+CA%22">Miller CA</searchLink>; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PL, England. Christopher.Miller@manchester.ac.uk.; Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, England. Christopher.Miller@manchester.ac.uk.; Division of Cell-Matrix Biology & Regenerative Medicine, School of Biology, Faculty of Biology, Medicine & Health, Manchester Academic Health Science Centre, Wellcome Centre for Cell-Matrix Research, University of Manchester, Oxford Road, Manchester, M13 9PT, England. Christopher.Miller@manchester.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100969716%22">The international journal of cardiovascular imaging</searchLink> [Int J Cardiovasc Imaging] 2022 Jul; Vol. 38 (7), pp. 1569-1578. <i>Date of Electronic Publication: </i>2022 Feb 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100969716 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1875-8312 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215695794%22">15695794 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cardiovasc Imaging <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35138474 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10554-022-02544-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1569 Titles: – TitleFull: Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lewis GA – PersonEntity: Name: NameFull: Rosala-Hallas A – PersonEntity: Name: NameFull: Dodd S – PersonEntity: Name: NameFull: Schelbert EB – PersonEntity: Name: NameFull: Williams SG – PersonEntity: Name: NameFull: Cunnington C – PersonEntity: Name: NameFull: McDonagh T – PersonEntity: Name: NameFull: Miller CA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2022 Jul Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1875-8312 Numbering: – Type: volume Value: 38 – Type: issue Value: 7 Titles: – TitleFull: The international journal of cardiovascular imaging Type: main |
| ResultId | 1 |